Bio-Rad Laboratories (BIO) Net Income towards Common Stockholders (2009 - 2026)
Bio-Rad Laboratories (BIO) recorded Net Income towards Common Stockholders of $371.4 million in Q2 2026, up 16.9% from $317.8 million a year earlier.
Bio-Rad Laboratories (BIO) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Bio-Rad Laboratories' Net Income towards Common Stockholders came in at $222.4 million as of Jun 30, 2026, down 30.3% year-over-year; for FY2025, it was $759.9 million.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of -27.6% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at -$1.84 billion in FY2024, -$637.3 million in FY2023, -$3.63 billion in FY2022 and $4.25 billion in FY2021 (+11.5%).
- Quarterly Net Income towards Common Stockholders has ranged from -$3.37 billion in Q1 2022 to $3.93 billion in Q3 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$527.1 million (Q1 2026), $720 million (Q4 2025) and -$341.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 818.10 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 241.90 Mn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 377.00 Mn |
| 10 | Bio-Rad Laboratories | 9.87 Bn | 3.73 Bn | 345.80 Mn | 371.40 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 371.40 Mn |
| Mar 31, 2026 | -527.10 Mn |
| Dec 31, 2025 | 720.00 Mn |
| Sep 30, 2025 | -341.90 Mn |
| Jun 30, 2025 | 317.80 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | -715.80 Mn |
| Sep 30, 2024 | 653.20 Mn |
| Jun 30, 2024 | -2.17 Bn |
| Mar 31, 2024 | 383.90 Mn |
| Dec 31, 2023 | 349.70 Mn |
| Sep 30, 2023 | 106.30 Mn |
| Jun 30, 2023 | -1.16 Bn |
| Mar 31, 2023 | 69.00 Mn |
| Dec 31, 2022 | 827.70 Mn |
| Sep 30, 2022 | -162.80 Mn |
| Jun 30, 2022 | -925.10 Mn |
| Mar 31, 2022 | -3.37 Bn |
| Dec 31, 2021 | -1.57 Bn |
| Sep 30, 2021 | 3.93 Bn |
Bio-Rad Laboratories Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();